This official website is maintained by the Claims
Administrator retained by and under the supervision of Plaintiffs' Lead
Counsel for the Class.
This website serves as an informational hub for the Settlement of the
securities class action, In re: King Pharmaceuticals, Inc. Securities
Litigation, No. 2:03-CV-77, in the United States District Court for the
Eastern District of Tennessee, Greeneville Division. As set forth in detail
in the Notice of Pendency of Class Action and Proposed Class Action
Settlement (the "Notice"), this suit was brought on behalf of all
persons or entities who purchased King Pharmaceuticals, Inc. Common Stock
between February 16, 1999, and March 10, 2003, inclusive (the "Class
Period"), including all persons or entities who acquired shares of King
Common Stock pursuant to any offering completed during the Class Period, and
who were damaged thereby ("Class Members").
IF YOU ARE A MEMBER OF THE CLASS DESCRIBED ABOVE, YOUR RIGHTS WILL BE
AFFECTED BY THE SETTLEMENT AND YOU MAY BE ENTITLED TO SHARE IN THE
SETTLEMENT FUND. If you have not yet received the Notice and Proof of Claim
and Release form, you may download it here or at
abdatalawserve.com,
or you can obtain copies by contacting:
In re: King
Pharmaceuticals, Inc. Securities Litigation
Claims Administrator
c/o A.B. Data, Ltd.
Post Office Box 170500
Milwaukee, WI 53217
(800) 949-0192
If you are a Class Member, in order to be eligible to share in the
distribution of the Net Settlement Fund, you must submit a Proof of Claim
and Release form postmarked no later than February 8, 2007, establishing
that you are entitled to a recovery. You will be bound by any judgment
entered in the Action whether or not you make a Claim.
If you desire to be excluded from the Class, you must file a request for
exclusion postmarked no later than December 26, 2006, in the manner and form
explained in the Notice. All Class Members who do not request to be excluded
from the Class will be bound by any judgment entered in the Action.
Any objection to the proposed Settlement, Plan of Allocation or
application for attorney fees and reimbursement of Litigation Expenses must
be filed with the Court and delivered to counsel for the parties postmarked
no later than December 26, 2006 in the manner and form set forth in the
Notice.
Inquiries, other than requests for the Notice and Proof of Claim and
Release form, may be made to Lead Counsel:
Jeffrey N. Leibell,
Esq.
BERNSTEIN LITOWITZ BERGER &
GROSSMANN LLP
1285 Avenue of the Americas
New York, NY 10019
(212) 554-1400
or
Jones Subclass Lead Counsel:
Joseph H. Weiss,
Esq.
Mark D. Smilow, Esq.
WEISS & LURIE
551 Fifth Avenue
New York, NY 10176
(212) 682-3025
Unless otherwise ordered by the Court, any Class Member who does not make
his, her or its objection or opposition in the manner provided shall be
deemed to have waived such objection.
